Real World Patient-reported Outcomes in HIV-infected Adults Switching to EVIPLERA(®), Because of a Previous Intolerance to cART. PRO-STR Study

BACKGROUND: To investigate the impact of switching from stable Combined Antiretroviral Therapy (cART) to single-tablet regimen (RPV/FTC/TDF=EVIPLERA®/COMPLERA®) on patient-reported outcomes in HIV-infected adults who cannot tolerate previous cART, in a real-world setting. METHODS: PRO-STR is a 48-we...

Descripción completa

Detalles Bibliográficos
Autores principales: Podzamczer, D., Rozas, N., Domingo, P., Miralles, C., Van den Eynde, E., Romero, A., Deig, E., Knobel, H., Pasquau, J., Antela, A., Clotet, B., Geijo, P., de Castro, E. Rodríguez, Casado, M.A., Muñoz, A., Casado, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6700757/
https://www.ncbi.nlm.nih.gov/pubmed/30760189
http://dx.doi.org/10.2174/1570162X17666190212163518

Ejemplares similares

Ejemplares similares